Buspirone is a partial 5-HT1A receptor agonist with anxiolytic activity and no dependence potential, used for generalised anxiety disorder as an alternative to benzodiazepines. Simson Pharma's Buspirone reference standard and impurities support compendial testing for this non-benzodiazepine anxiolytic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Buspirone Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.